These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32167038)

  • 21. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    Semá Baltazar C; Rafael F; Langa JPM; Chicumbe S; Cavailler P; Gessner BD; Pezzoli L; Barata A; Zaina D; Inguane DL; Mengel MA; Munier A
    PLoS One; 2018; 13(10):e0198592. PubMed ID: 30281604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
    Saha A; Hayen A; Ali M; Rosewell A; MacIntyre CR; Clemens JD; Qadri F
    Vaccine; 2018 Jul; 36(31):4742-4749. PubMed ID: 29752024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia.
    Park SE; Gedefaw A; Hailu D; Jeon Y; Mogeni OD; Jang GH; Mukasa D; Mraidi R; Kim DR; Getahun T; Mesfin Getachew E; Yeshitela B; Ayele Abebe S; Hussen M; Worku Demlie Y; Teferi M
    Clin Infect Dis; 2024 Jul; 79(Supplement_1):S33-S42. PubMed ID: 38996035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Ray A; Sarkar K; Haldar P; Ghosh R
    Vaccine; 2020 Feb; 38 Suppl 1():A184-A193. PubMed ID: 31377080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti.
    Aibana O; Franke MF; Teng JE; Hilaire J; Raymond M; Ivers LC
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2576. PubMed ID: 24278498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
    Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
    Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
    Schaetti C; Weiss MG; Ali SM; Chaignat CL; Khatib AM; Reyburn R; Duintjer Tebbens RJ; Hutubessy R
    PLoS Negl Trop Dis; 2012; 6(10):e1844. PubMed ID: 23056660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti.
    Matias WR; Guillaume Y; Cene Augustin G; Vissieres K; Ternier R; Slater DM; Harris JB; Franke MF; Ivers LC
    Int J Infect Dis; 2024 Feb; 139():153-158. PubMed ID: 38000510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
    Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
    Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
    Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
    N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Cholera Vaccine Coverage during an Outbreak and Humanitarian Crisis, Iraq, 2015.
    Lam E; Al-Tamimi W; Russell SP; Butt MO; Blanton C; Musani AS; Date K
    Emerg Infect Dis; 2017 Jan; 23(1):38-45. PubMed ID: 27983502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
    Qadri F; Wierzba TF; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Asaduzzaman M; Akter A; Khan A; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Islam T; Chowdhury AI; Rahman A; Siddique SA; You YA; Kim DR; Siddik AU; Saha NC; Kabir A; Cravioto A; Desai SN; Singh AP; Clemens JD
    N Engl J Med; 2016 May; 374(18):1723-32. PubMed ID: 27144848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy Outcomes after a Mass Vaccination Campaign with an Oral Cholera Vaccine in Guinea: A Retrospective Cohort Study.
    Grout L; Martinez-Pino I; Ciglenecki I; Keita S; Diallo AA; Traore B; Delamou D; Toure O; Nicholas S; Rusch B; Staderini N; Serafini M; Grais RF; Luquero FJ
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004274. PubMed ID: 26713614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.
    Burnett EM; Francois J; Sreenivasan N; Wannemuehler K; Faye PC; Tohme RA; Delly P; Deslouches YG; Etheart MD; Dismer AM; Patel R; Date K
    Vaccine; 2019 Oct; 37(43):6348-6355. PubMed ID: 31521413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.
    Qadri F; Ali M; Lynch J; Chowdhury F; Khan AI; Wierzba TF; Excler JL; Saha A; Islam MT; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Khan IA; Kabir A; Riaz BK; Akter A; Khan A; Asaduzzaman M; Kim DR; Siddik AU; Saha NC; Cravioto A; Singh AP; Clemens JD
    Lancet Infect Dis; 2018 Jun; 18(6):666-674. PubMed ID: 29550406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
    Démolis R; Botão C; Heyerdahl LW; Gessner BD; Cavailler P; Sinai C; Magaço A; Le Gargasson JB; Mengel M; Guillermet E
    Vaccine; 2018 Oct; 36(44):6497-6505. PubMed ID: 29174106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
    Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Mobile Health (mHealth) and geospatial mapping technology in a mass campaign for reactive oral cholera vaccination in rural Haiti.
    Teng JE; Thomson DR; Lascher JS; Raymond M; Ivers LC
    PLoS Negl Trop Dis; 2014; 8(7):e3050. PubMed ID: 25078790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.